Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other ...
Omega Therapeutics is halting work on its only clinical-stage candidate as part of a strategic refocus centered on three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback